
U.S. Senators Raise Alarm on Meta's Spam Ads, iPhone Air Sales Dissapoint
The Rundown
00:00
Novo Nordisk Alzheimer's trial setback
Zaid explains the failed semi-glutide trial, missed endpoints and the resulting stock decline for Novo Nordisk.
Play episode from 06:06
Transcript


